-
A MULTI-DIMENSIONAL WEIGHTING METHODOLOGY FOR EVALUATING PATIENT-REPORTED OUTCOME EVIDENCE TO OPTIMIZE AND DIFFERENTIATE A MARKETED TREATMENT
Mar 18, 2026, 21:38 PM -
IDENTIFYING ONCOLOGY PATIENT SUBTYPES USING ELECTRONICPATIENT-REPORTED OUTCOMES (EPROS)DEPLOYED INCLINICAL PRACTICE: A PATIENT-CENTRIC APPROACH TO MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
EARLY-LIFE PAIN EXPERIENCES AND DEPRESSION ONSET AMONG CHILDREN WITH SICKLE CELL DISEASE A LONGITUDINAL ANALYSIS USING TEXAS MEDICAID DATA
Mar 18, 2026, 21:38 PM -
INSURANCE DENIALS AND DISCONTINUATION OF GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONISTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
MARGINAL HEALTHCARE EXPENDITURE BURDEN OF PATIENTS WITH DEPRESSIVE DISORDERS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AMONG PEDIATRIC POPULATIONS BY WEIGHT STATUS
Mar 18, 2026, 21:38 PM -
ESTIMATION OF FAIRNESS OF DISTRIBUTION OF HUNGARIAN HOSPITAL BEDS BY CALCULATING GINI COEFFICIENT
Mar 18, 2026, 21:38 PM -
EXPLORING LIFE SATISFACTION AS AN OUTCOME OF INTEREST FOR VALUE ASSESSMENT
Mar 18, 2026, 21:38 PM -
PREVALENCE OF POLYCYSTIC OVARY SYNDROME (PCOS) AND BURDEN OF DISEASE AMONG WOMEN AGES 18-44 IN THE US, NATIONAL HEALTH AND WELLNESS SURVEY
Mar 18, 2026, 21:38 PM -
SHOULD PHASE 2 STUDIES BE ROUTINELY EXCLUDED IN COMPARATIVE EFFECTIVENESS ITCS?
Mar 18, 2026, 21:38 PM -
CHARACTERIZING THE USE OF DIGITAL HEALTH TECHNOLOGY-DERIVED ENDPOINTS TO CAPTURE PATIENT EXPERIENCE DATA IN CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATIONS OF HYPERTENSION INTERVENTIONS IN PREGNANCY LACK STANDARDISATION: RESULTS OF A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
UTILIZATION OF TARLATAMAB AND ASSOCIATED HEALTHCARE RESOURCE USE, COSTS, AND ADVERSE EVENTS: A RETROSPECTIVE COHORT STUDY USING A LARGE U.S. HOSPITAL DATABASE
Mar 18, 2026, 21:38 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ABOUT THE STATE OF HEOR
Mar 18, 2026, 21:38 PM -
DIRECT MEDICAL COSTS SAVED BY EARLY PAH DETECTION USING A MACHINE LEARNING ALGORITHM
Mar 18, 2026, 21:38 PM -
EXCESS HEALTHCARE COSTS OF OVERT HEPATIC ENCEPHALOPATHY (OHE) RELATIVE TO NON-OHE CIRRHOSIS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
PATIENT EXPERIENCES WITH HEALTH CARE TRANSITION IN YOUNG ADULTS WITH SICKLE CELL DISEASE
Mar 18, 2026, 21:38 PM -
APPROVED AND EMERGING OPTIONS FOR ONCOLOGY TREATMENT-RELATED TOXICITIES: A TARGETED LITERATURE REVIEW OF THE LANDSCAPE AND REMAINING UNMET NEEDS
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR LONG-ACTING PREP ADMINISTRATION AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
BENCHMARKING GENERATIVE AI TOOLS FOR COST-EFFECTIVENESS ANALYSIS (CEA) MODEL INPUT CURATION: A COMPARATIVE EVALUATION OF LARGE LANGUAGE MODELS
Mar 18, 2026, 21:09 PM
